The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Idorsia Ltd is reaching out for more – We have more ideas, we see more opportunities and we want to help more patients. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical
Associate Director, Technical Project Leader Drug Product Location: Basel, CH The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is
Associate Director, Technical Project Leader Drug Substance Location: Basel, CH The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is
Please note that we can only accept applicants who are eligible to work in Europe or in possession of a valid work permit. Second Engineer River - Nautic Viking (NYSE: VIK) was founded in 1997 and
Media Technician (f/m/d) Entertainment Technology - Mein Schiff Charterer: TUI Cruises / Mein Schiff Department: Entertainment WANDERLUST? You love the sea and providing world class experiences? Start your adventure onboard the Mein Schiff® Fleet: The growing
Cyber Security Engineer Location: Allschwil, Basel Area, BL, CH The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. To achieve this, we will develop Idorsia into a leading biopharmaceutical